ARISING HEALTHALIVE. AWAKE. AWARE.Read the magazines →

← November 8, 2026 edited reader edition

THE ARISING · Longevity & Healthspan

A Trial Will Test Whether Two Medicines Preserve Everyday Physical Function

VITAL-H plans to test oral semaglutide and dapagliflozin separately against placebo in older adults. No results have been posted.

Standing up from a chair, walking steadily, and keeping your balance are everyday parts of independence. A registered trial will ask whether two existing medicines can help people preserve those abilities as they age.

The University of Texas Health Science Center at San Antonio plans to enroll 1,200 adults aged 60 to 75 in VITAL-H, a randomized, double-blind Phase 2b study. It will compare oral semaglutide, dapagliflozin, and placebo in three separate groups. The active medicines are not being tested together. The registry describes three years of treatment followed by six months of observation.

The study’s primary measure is the Short Physical Performance Battery, which combines tests of walking speed, standing balance, and repeated chair stands. Exercise capacity is a secondary measure. The study is designed to test physical function. It is not designed to establish whether either drug extends lifespan.

At the time of the November 8 issue, the November 6 registry entry listed the trial as not yet recruiting. The registry still supplied no results at editorial recheck. The enrollment figure is a target, not a count of people already enrolled. The eligibility criteria exclude people with diabetes and some other medical conditions, so any future findings will need to be interpreted in the population actually studied.

The noteworthy step is what the trial sets out to measure: abilities that matter in daily life rather than a laboratory marker alone. The trial registration is not evidence that either medication slows aging and is not a reason to start taking one for that purpose.

VITAL-H study record on ClinicalTrials.gov

THE ARISING NEWSLETTER

Science moves forward.
Come with it.

Research, clear explanations, and a little room for wonder.
Read and follow The Arising on Substack.

Find The Arising on Substack ↗